Peter Jorth

2.6k total citations · 1 hit paper
35 papers, 1.2k citations indexed

About

Peter Jorth is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Molecular Medicine. According to data from OpenAlex, Peter Jorth has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Medicine. Recurrent topics in Peter Jorth's work include Bacterial biofilms and quorum sensing (15 papers), Antibiotic Resistance in Bacteria (11 papers) and Cystic Fibrosis Research Advances (10 papers). Peter Jorth is often cited by papers focused on Bacterial biofilms and quorum sensing (15 papers), Antibiotic Resistance in Bacteria (11 papers) and Cystic Fibrosis Research Advances (10 papers). Peter Jorth collaborates with scholars based in United States, Canada and China. Peter Jorth's co-authors include Marvin Whiteley, Pınar Gümüş, Keith H. Turner, Nurcan Buduneli, Nejat Nizam, Marvin Whiteley, Urvish Trivedi, Kendra P. Rumbaugh, Apollo Stacy and Jake Everett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Peter Jorth

32 papers receiving 1.2k citations

Hit Papers

Pharmacologic improvement of CFTR function rapidly decrea... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Jorth United States 17 654 279 206 190 176 35 1.2k
Kelly M. Colvin United States 8 889 1.4× 208 0.7× 135 0.7× 85 0.4× 201 1.1× 8 1.2k
Laetitia Charron‐Mazenod Canada 9 753 1.2× 146 0.5× 144 0.7× 94 0.5× 117 0.7× 10 1.0k
Jake Everett United States 9 587 0.9× 147 0.5× 92 0.4× 48 0.3× 135 0.8× 15 890
Matthew S. Byrd United States 11 899 1.4× 221 0.8× 141 0.7× 127 0.7× 184 1.0× 11 1.2k
Heidi Mulcahy Canada 11 909 1.4× 122 0.4× 180 0.9× 94 0.5× 231 1.3× 11 1.3k
Kabilan Velliyagounder United States 16 556 0.9× 364 1.3× 137 0.7× 68 0.4× 70 0.4× 25 1.1k
Deborah R. Yoder-Himes United States 15 734 1.1× 92 0.3× 256 1.2× 94 0.5× 365 2.1× 30 1.3k
Era A. Izano United States 10 967 1.5× 297 1.1× 156 0.8× 46 0.2× 79 0.4× 10 1.3k
Laura Filkins United States 13 578 0.9× 53 0.2× 86 0.4× 304 1.6× 105 0.6× 35 1.0k
Rebecca Munk Vejborg Denmark 19 784 1.2× 79 0.3× 225 1.1× 57 0.3× 227 1.3× 22 1.3k

Countries citing papers authored by Peter Jorth

Since Specialization
Citations

This map shows the geographic impact of Peter Jorth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jorth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jorth more than expected).

Fields of papers citing papers by Peter Jorth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jorth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jorth. The network helps show where Peter Jorth may publish in the future.

Co-authorship network of co-authors of Peter Jorth

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jorth. A scholar is included among the top collaborators of Peter Jorth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jorth. Peter Jorth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortega, Humberto E., Mylène Vaillancourt, Anna Clara Milesi Galdino, et al.. (2025). Evolutionary loss of an antibiotic efflux pump increases Pseudomonas aeruginosa quorum sensing mediated virulence in vivo. Nature Communications. 16(1). 8397–8397.
2.
Vaillancourt, Mylène, et al.. (2025). A chronic Pseudomonas aeruginosa mouse lung infection modeling the mucus obstruction, lung function, and inflammation of human cystic fibrosis. Infection and Immunity. 93(7). e0023025–e0023025. 1 indexed citations
3.
Faure, Emmanuel, Damien Adam, Lin Liu, et al.. (2024). Intracellular Pseudomonas aeruginosa within the Airway Epithelium of Cystic Fibrosis Lung Tissues. American Journal of Respiratory and Critical Care Medicine. 209(12). 1453–1462. 7 indexed citations
4.
Abdul‐Mutakabbir, Jacinda C., Peter Jorth, Victor Nizet, et al.. (2024). Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii. Antibiotics. 13(1). 47–47. 2 indexed citations
5.
Galdino, Anna Clara Milesi, et al.. (2024). Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro. Nature Microbiology. 9(3). 631–646. 20 indexed citations
6.
Faure, Emmanuel, Damien Adam, Lijie Liu, et al.. (2023). 74 Intracellular Pseudomonas aeruginosa in cystic fibrosis lung tissues. Journal of Cystic Fibrosis. 22. S39–S39. 1 indexed citations
7.
Nichols, David P., Sarah J. Morgan, M. Skalland, et al.. (2023). Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist. Journal of Clinical Investigation. 133(10). 106 indexed citations breakdown →
8.
Vaillancourt, Mylène, Anna Clara Milesi Galdino, Catherine Bresee, et al.. (2023). A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infection. PLoS Pathogens. 19(4). e1010942–e1010942. 9 indexed citations
9.
Vaillancourt, Mylène, et al.. (2023). 101 Pyochelin-overexpressing Pseudomonas aeruginosa mutants evade immune clearance by inducing macrophage ferroptosis. Journal of Cystic Fibrosis. 22. S53–S53. 1 indexed citations
12.
Vaillancourt, Mylène, et al.. (2021). Pseudomonas aeruginosa mexR and mexEF Antibiotic Efflux Pump Variants Exhibit Increased Virulence. Antibiotics. 10(10). 1164–1164. 21 indexed citations
13.
Morgan, Sarah J., Sumedha Ravishankar, Peter Jorth, et al.. (2021). A population-level strain genotyping method to study pathogen strain dynamics in human infections. JCI Insight. 6(24). 3 indexed citations
14.
Michaels, Lia A., et al.. (2021). The anti‐sigma factor MucA is required for viability in Pseudomonas aeruginosa. Molecular Microbiology. 116(2). 550–563. 12 indexed citations
15.
Peñaloza, Hernán F., William Bain, Mei Hulver, et al.. (2021). Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality. CHEST Journal. 160(5). 1624–1633. 17 indexed citations
17.
Bulterys, Philip L., Michael D. Bartberger, Peter Jorth, et al.. (2019). Incorporation of a chiral gem-disubstituted nitrogen heterocycle yields an oxazolidinone antibiotic with reduced mitochondrial toxicity. Bioorganic & Medicinal Chemistry Letters. 29(18). 2686–2689. 12 indexed citations
18.
Stacy, Apollo, et al.. (2016). Microbial Community Composition Impacts Pathogen Iron Availability during Polymicrobial Infection. PLoS Pathogens. 12(12). e1006084–e1006084. 25 indexed citations
19.
Chevallereau, Anne, Bob Blasdel, Jeroen De Smet, et al.. (2016). Next-Generation “-omics” Approaches Reveal a Massive Alteration of Host RNA Metabolism during Bacteriophage Infection of Pseudomonas aeruginosa. PLoS Genetics. 12(7). e1006134–e1006134. 85 indexed citations
20.
Stacy, Apollo, Jake Everett, Peter Jorth, et al.. (2014). Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection. Proceedings of the National Academy of Sciences. 111(21). 7819–7824. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026